EUVIMEDEUVIMED entdecken
Crossref

Temporal trends in cancer among the oldest-old: incidence, stage at diagnosis, treatment and survival. A population-based study, Hérault, France, 1990–2022

Claudine Gras-Aygon, Anne-Sophie Foucan, Brigitte Tretarre

Cancer Epidemiology · 2026

DOI: 10.1016/j.canep.2026.103201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Epidemiology, 2026. Verfasst von Claudine Gras-Aygon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Registre des tumeurs de l'Hérault, Montpellier, France. Electronic address: gras-aygon.claudine@registre-tumeurs-herault.fr. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The rising burden of cancer in the ageing population represents a major public health issue, especially among the oldest age groups. There is limited data available on the cancer burden and care for the oldest age groups, particularly for those aged 85 and over. This study aimed to analyze trends in cancer incidence rates, stage at diagnosis, primary treatment, and net survival in an older population in a French administrative district from 1990 to 2022. METHODS: All new invasive cancers diagnosed in individuals aged ≥ 75 years and recorded in the Hérault cancer registry from 1990 to 2022 were included. Patients were categorized into four age groups (75-79, 80-84, 85-89, ≥90 years). Temporal trends in incidence, stage distribution, treatment, and net survival were analyzed using Joinpoint regression models. RESULTS: Among 55,571 cases aged ≥ 75 years, 15,377 (27.6%) occurred in individuals aged ≥ 85 years. Incidence increased with age, the sharpest increase was in ≥ 90 years (+1.9% per year). Metastatic and unknown-stage cancers increased with age, but decreased over time. The proportion of patients receiving no active treatment increased with age; declining over time in those aged 75-89 but remaining stable at ∼60% in patients ≥ 90 years. Three-year survival for patients aged ≥ 75 remained stable over time at around 55%. CONCLUSION: The increasing burden at the oldest ages highlights the need to adapt care pathways through an approach that is individualized, multidisciplinary, and informed by geriatric expertise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansFranceAged, 80 and overIncidenceFemaleMaleNeoplasm StagingAgedRegistriesSurvival Rate

Stichwörter der Autor:innen

CancerIncidenceNet survivalOldest-oldStageTreatmentTrend

Autor:innen und Institutionen

  • Registre des tumeurs de l'Hérault, Montpellier, France. Electronic address: gras-aygon.claudine@registre-tumeurs-herault.fr.
  • Registre des Tumeurs de l'Hérault, France.
  • Registre des Tumeurs de l'Hérault et CERPOP, France.

Zitieren

APA

Gras-Aygon, C., Foucan, A. S., & Tretarre, B. (2026). Temporal trends in cancer among the oldest-old: incidence, stage at diagnosis, treatment and survival. A population-based study, Hérault, France, 1990–2022. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2026.103201

Vancouver

Gras-Aygon C, Foucan AS, Tretarre B. Temporal trends in cancer among the oldest-old: incidence, stage at diagnosis, treatment and survival. A population-based study, Hérault, France, 1990–2022. Cancer Epidemiology. 2026. doi:10.1016/j.canep.2026.103201

BibTeX
@article{GrasAygon2026,
  author = {Gras-Aygon, Claudine and Foucan, Anne-Sophie and Tretarre, Brigitte},
  title = {Temporal trends in cancer among the oldest-old: incidence, stage at diagnosis, treatment and survival. A population-based study, Hérault, France, 1990–2022},
  journal = {Cancer Epidemiology},
  year = {2026},
  doi = {10.1016/j.canep.2026.103201}
}
Kostenlos starten →